Centers for Medicare & Medicaid Services #260265J

CMS Solicitation for Implementation and Monitoring of GUARD and GLOBE Drug Pricing Models

This opportunity is issued by the Centers for Medicare & Medicaid Services (CMS), under the Department of Health and Human Services. - CMS seeks a contractor to implement and monitor two new drug pricing models: - GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model for Medicare Part D - GLOBE (Global Benchmark for Efficient Drug Pricing) Model for Medicare Part B - The models require assessment of rebates for certain drugs if U.S. prices exceed those in economically comparable countries - No specific Original Equipment Manufacturers (OEMs) or vendors are named in the solicitation - The contract will be a Cost Plus Fixed Fee IDIQ/GWAC order under the CMS RMADA 2 IDIQ - Estimated contract value is between $50 million and $100 million - Key requirements include: - Expertise in drug pricing analytics and international price benchmarking - Experience with Medicare program operations and rebate assessment - Ability to implement and monitor large-scale healthcare payment models

Description

The solicitation is for the implementation and monitoring of the GUARD and GLOBE Models, which are proposed mandatory models assessing rebates for certain drugs payable under Medicare Parts B and D if prices exceed those in economically comparable countries. The GUARD Model focuses on Medicare Part D drug rebates, while the GLOBE Model addresses Medicare Part B drug rebates. The contract is anticipated to start in September 2026 and last for more than five years, with an estimated contract value between $50 million and $100 million. The contract type is a Cost Plus Fixed Fee under an IDIQ/GWAC order, associated with the CMS RMADA 2 IDIQ.

View original listing